Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Welcome and Introduction to Vi3C

Advertisement

Advertisement

Sep

26

Today In Oncology

Risk Factors for Melanoma Among Individuals Living in Atlantic Canada

Particulate Matter Concentrations and Incidence of Breast Cancer

Lung MAP Study May Improve Access to Clinical Trials for Underrepresented Patients

Magrolimab Plus Azacitidine in Previously Untreated Patients With AML Ineligible for Intensive Chemotherapy

Curettage and Cryosurgery May Be Effective for Patients With Basal Cell Carcinoma

Advertisement

© 2023 HSP News Service, L.L.C.

Designed by Harborside